| 2024 |
| 04/24 | 6,359 | 6,383 | 6,307 | 6,358 | +0.28% | 971,800 | 3兆5467億 | +0.65% |
| 04/23 | 6,342 | 6,408 | 6,324 | 6,340 | +0.28% | 653,300 | 3兆5366億 | +0.38% |
| 04/22 | 6,286 | 6,347 | 6,221 | 6,322 | +2.2% | 706,700 | 3兆5266億 | +0.11% |
| 04/19 | 6,160 | 6,210 | 6,066 | 6,186 | -0.13% | 1,008,800 | 3兆4507億 | -1.89% |
| 04/18 | 6,239 | 6,292 | 6,186 | 6,194 | -1.07% | 777,700 | 3兆4552億 | -1.64% |
| 04/17 | 6,301 | 6,329 | 6,256 | 6,261 | -1.18% | 643,400 | 3兆4926億 | -0.46% |
| 04/16 | 6,301 | 6,360 | 6,257 | 6,336 | -0.16% | 921,200 | 3兆5344億 | +0.92% |
| 04/15 | 6,300 | 6,391 | 6,270 | 6,346 | -0.63% | 688,400 | 3兆5400億 | +1.33% |
| 04/12 | 6,392 | 6,415 | 6,311 | 6,386 | +1.28% | 1,036,400 | 3兆5623億 | +2.13% |
| 04/11 | 6,250 | 6,314 | 6,205 | 6,305 | -0.36% | 961,900 | 3兆5171億 | +1.09% |
| 04/10 | 6,363 | 6,386 | 6,304 | 6,328 | +1.04% | 837,600 | 3兆5299億 | +1.64% |
| 04/09 | （IR情報）15:00 抗精神病薬「ブレクスピプラゾール」米国で新規効能を追加申請-成人の心的外傷後ストレス障害(PTSD)について- |
| 04/09 | 6,250 | 6,282 | 6,204 | 6,263 | -0.1% | 615,100 | 3兆4937億 | +0.76% |
| 04/08 | 6,230 | 6,306 | 6,224 | 6,269 | +0.82% | 834,800 | 3兆4970億 | +1% |
| 04/05 | 6,220 | 6,245 | 6,137 | 6,218 | -1.55% | 1,335,900 | 3兆4686億 | +0.31% |
| 04/04 | （IR情報）15:30 (訂正)「「エビリファイメンテナ960mg」統合失調症維持療法を対象とした欧州初となる2か月持続性製剤の承認を取得」の一部訂正について |
| 04/04 | 6,350 | 6,398 | 6,294 | 6,316 | -0.52% | 1,109,200 | 3兆5232億 | +1.99% |
| 04/03 | 6,369 | 6,408 | 6,283 | 6,349 | -0.33% | 1,358,300 | 3兆5416億 | +2.62% |
| 04/02 | 6,368 | 6,430 | 6,329 | 6,370 | +0.58% | 1,181,300 | 3兆5534億 | +3.14% |
| 04/01 | 6,324 | 6,373 | 6,275 | 6,333 | +0.36% | 557,500 | 3兆5327億 | +2.94% |
| 03/29 | 6,315 | 6,329 | 6,248 | 6,310 | +0.62% | 1,107,900 | 3兆5199億 | +3.04% |
| 03/28 | （IR情報）15:00 譲渡制限付株式報酬としての自己株式の処分に関するお知らせ |
| 03/28 | 6,379 | 6,414 | 6,251 | 6,271 | -1.74% | 1,106,800 | 3兆4981億 | +2.89% |
| 03/27 | （IR情報）17:00 「エビリファイメンテナ960mg」統合失調症維持療法を対象とした欧州初となる2か月持続性製剤の承認を取得 |
| 03/27 | 6,300 | 6,418 | 6,290 | 6,382 | +1.48% | 1,197,500 | 3兆5601億 | +5.19% |
| 03/26 | 6,262 | 6,312 | 6,212 | 6,289 | -0.46% | 764,300 | 3兆5082億 | +4.26% |
| 03/25 | 6,480 | 6,480 | 6,310 | 6,318 | -2.32% | 873,200 | 3兆5244億 | +5.21% |
| 03/22 | 6,431 | 6,510 | 6,429 | 6,468 | +0.94% | 1,116,000 | 3兆6080億 | +8.36% |
| 03/21 | 6,407 | 6,431 | 6,352 | 6,408 | +1.3% | 1,146,200 | 3兆5746億 | +8.1% |
| 03/19 | 6,280 | 6,326 | 6,192 | 6,326 | +0.03% | 1,278,500 | 3兆5288億 | +7.48% |
| 03/18 | 6,150 | 6,360 | 6,149 | 6,324 | +4.36% | 1,199,800 | 3兆5277億 | +7.95% |
| 03/15 | （IR情報）15:30 住友ファーマとのライセンス契約改定に関するお知らせ |
| 03/15 | 6,030 | 6,113 | 6,010 | 6,060 | +1.05% | 1,209,200 | 3兆3804億 | +3.91% |
| 03/14 | 5,994 | 6,052 | 5,960 | 5,997 | -0.15% | 1,113,600 | 3兆3453億 | +3.13% |
| 03/13 | 5,995 | 6,008 | 5,938 | 6,006 | +0.4% | 988,300 | 3兆3503億 | +3.52% |
| 03/12 | 6,000 | 6,006 | 5,895 | 5,982 | +0.42% | 996,200 | 3兆3369億 | +3.3% |
| 03/11 | 6,016 | 6,023 | 5,855 | 5,957 | -1.99% | 1,160,200 | 3兆3230億 | +3.08% |
| 03/08 | 6,000 | 6,078 | 5,927 | 6,078 | +1.3% | 1,667,900 | 3兆3905億 | +5.32% |
| 03/07 | 6,019 | 6,074 | 5,972 | 6,000 | -0.43% | 1,053,600 | 3兆3470億 | +4.17% |
| 03/06 | 6,089 | 6,120 | 6,019 | 6,026 | -0.87% | 1,117,800 | 3兆3615億 | +4.78% |
| 03/05 | 6,004 | 6,088 | 6,001 | 6,079 | +0.56% | 888,900 | 3兆3910億 | +5.83% |
| 03/04 | 6,006 | 6,093 | 6,004 | 6,045 | -0.15% | 980,400 | 3兆3721億 | +5.46% |
| 03/01 | 6,059 | 6,096 | 6,011 | 6,054 | -0.46% | 756,800 | 3兆3771億 | +5.82% |
| 02/29 | 6,147 | 6,169 | 6,055 | 6,082 | -1.14% | 1,335,900 | 3兆3927億 | +6.5% |
| 02/28 | 6,088 | 6,173 | 6,063 | 6,152 | +1.28% | 1,356,600 | 3兆4318億 | +7.85% |
| 02/27 | 5,840 | 6,087 | 5,840 | 6,074 | +5.23% | 2,271,000 | 3兆3882億 | +6.71% |
| 02/26 | 5,683 | 5,814 | 5,683 | 5,772 | +2.38% | 1,237,200 | 3兆2198億 | +1.6% |
| 02/22 | 5,584 | 5,678 | 5,580 | 5,638 | +0.75% | 995,400 | 3兆1450億 | -0.79% |
| 02/21 | 5,559 | 5,623 | 5,542 | 5,596 | +0.67% | 993,400 | 3兆1216億 | -1.65% |
| 02/20 | 5,527 | 5,625 | 5,506 | 5,559 | +0.85% | 862,000 | 3兆1010億 | -2.42% |
| 02/19 | 5,574 | 5,624 | 5,495 | 5,512 | -1.61% | 806,200 | 3兆747億 | -3.48% |
| 02/16 | 5,482 | 5,661 | 5,482 | 5,602 | +3.21% | 1,735,600 | 3兆1249億 | -2.13% |
| 02/15 | 5,440 | 5,506 | 5,338 | 5,428 | -0.11% | 2,480,200 | 3兆279億 | -5.35% |
| 02/14 | （IR情報）13:30 剰余金の配当に関するお知らせ |
| 02/14 | （IR情報）13:30 当社グループ従業員持株会を通じた「特別奨励金スキーム」の導入について |
| 02/14 | （IR情報）13:30 譲渡制限付株式報酬制度の改定に関するお知らせ |
| 02/14 | （IR情報）13:30 個別業績の前期実績との差異に関するお知らせ |
| 02/14 | （IR情報）13:30 2023年12月期決算短信〔IFRS〕(連結) |
| 02/14 | 5,410 | 5,614 | 5,261 | 5,434 | +1.4% | 3,347,500 | 3兆312億 | -5.48% |
| 02/13 | （IR情報）16:30 (数値データ追加)「業績予想の修正に関するお知らせ」におけるXBRLデータ追加について |
| 02/13 | 5,044 | 5,359 | 5,030 | 5,359 | -5.05% | 3,274,800 | 2兆9894億 | -6.91% |
| 02/13 | （IR情報）8:00 業績予想の修正に関するお知らせ |
| 02/13 | （IR情報）8:00 アルツハイマー型認知症に伴うアジテーションを対象とした「AVP-786」のフェーズ3試験結果速報について |
| 02/09 | 5,646 | 5,777 | 5,623 | 5,644 | -0.25% | 1,397,900 | 3兆1484億 | -2.12% |
| 02/08 | 5,621 | 5,689 | 5,577 | 5,658 | +0.5% | 1,045,900 | 3兆1562億 | -1.77% |
| 02/07 | 5,635 | 5,707 | 5,583 | 5,630 | -0.81% | 850,100 | 3兆1406億 | -2% |
| 02/06 | 5,694 | 5,745 | 5,642 | 5,676 | -1.13% | 870,900 | 3兆1662億 | -0.98% |
| 02/05 | 5,695 | 5,764 | 5,689 | 5,741 | +0.93% | 578,200 | 3兆2025億 | +0.33% |
| 02/02 | 5,761 | 5,779 | 5,685 | 5,688 | -0.85% | 703,200 | 3兆1729億 | -0.37% |
| 02/01 | 5,801 | 5,815 | 5,733 | 5,737 | -1.49% | 591,400 | 3兆2003億 | +0.67% |
| 01/31 | 5,699 | 5,824 | 5,690 | 5,824 | +0.85% | 916,100 | 3兆2488億 | +2.5% |
| 01/30 | 5,855 | 5,855 | 5,757 | 5,775 | -1.11% | 854,300 | 3兆2215億 | +2.05% |
| 01/29 | 5,805 | 5,868 | 5,805 | 5,840 | +0.95% | 730,500 | 3兆2577億 | +3.56% |
| 01/26 | 5,794 | 5,817 | 5,752 | 5,785 | +0.49% | 813,300 | 3兆2270億 | +3.05% |
| 01/25 | 5,773 | 5,825 | 5,747 | 5,757 | -0.79% | 601,300 | 3兆2114億 | +2.99% |
| 01/24 | 5,839 | 5,873 | 5,786 | 5,803 | -1.83% | 738,100 | 3兆2371億 | +4.2% |
| 01/23 | 5,876 | 5,974 | 5,871 | 5,911 | +0.85% | 720,500 | 3兆2973億 | +6.45% |
| 01/22 | 5,836 | 5,874 | 5,816 | 5,861 | +1.23% | 504,400 | 3兆2694億 | +5.81% |
| 01/19 | 5,828 | 5,847 | 5,738 | 5,790 | -0.58% | 933,500 | 3兆2298億 | +4.64% |
| 01/18 | 5,836 | 5,872 | 5,787 | 5,824 | +0.28% | 923,300 | 3兆2488億 | +5.34% |
| 01/17 | 5,816 | 5,892 | 5,787 | 5,808 | +0.29% | 893,100 | 3兆2399億 | +5.24% |
| 01/16 | 5,864 | 5,871 | 5,774 | 5,791 | -1.93% | 770,400 | 3兆2304億 | +4.99% |
| 01/15 | 5,803 | 5,915 | 5,790 | 5,905 | +1.22% | 624,400 | 3兆2940億 | +7.07% |
| 01/12 | 5,960 | 5,977 | 5,819 | 5,834 | -0.58% | 1,389,900 | 3兆2544億 | +5.96% |
| 01/11 | 5,875 | 5,883 | 5,826 | 5,868 | +1.61% | 1,278,100 | 3兆2733億 | +6.69% |
| 01/10 | 5,707 | 5,812 | 5,679 | 5,775 | +2.39% | 1,409,200 | 3兆2215億 | +5.11% |
| 01/09 | 5,634 | 5,677 | 5,603 | 5,640 | +0.95% | 1,205,800 | 3兆1461億 | +2.71% |
| 01/05 | 5,546 | 5,612 | 5,546 | 5,587 | +1.75% | 1,164,800 | 3兆1166億 | +1.77% |
| 01/04 | 5,373 | 5,491 | 5,309 | 5,491 | +3.82% | 1,075,600 | 3兆630億 | -0.02% |
| 2023 |
| 12/29 | 5,284 | 5,332 | 5,244 | 5,289 | -0.09% | 1,032,600 | 2兆9503億 | -3.78% |
| 12/28 | 5,374 | 5,401 | 5,291 | 5,294 | -2.61% | 837,500 | 2兆9531億 | -3.97% |
| 12/27 | 5,418 | 5,460 | 5,390 | 5,436 | +0.39% | 1,390,800 | 3兆323億 | -1.59% |
| 12/26 | 5,441 | 5,457 | 5,390 | 5,415 | -0.22% | 778,500 | 3兆206億 | -2.01% |
| 12/25 | 5,417 | 5,464 | 5,415 | 5,427 | +2.07% | 846,800 | 3兆273億 | -1.84% |
| 12/22 | （IR情報）15:00 抗精神病薬「レキサルティ」うつ病・うつ状態の日本における効能追加の承認取得 |
| 12/22 | 5,255 | 5,332 | 5,255 | 5,317 | +1.2% | 846,200 | 2兆9660億 | -3.9% |
| 12/21 | 5,260 | 5,290 | 5,212 | 5,254 | -0.36% | 1,185,500 | 2兆9308億 | -5.16% |
| 12/20 | 5,236 | 5,310 | 5,216 | 5,273 | +1.29% | 979,200 | 2兆9414億 | -5.03% |
| 12/19 | 5,193 | 5,236 | 5,170 | 5,206 | +0.42% | 847,100 | 2兆9040億 | -6.4% |
| 12/18 | 5,184 | 5,200 | 5,118 | 5,184 | -0.88% | 1,205,100 | 2兆8918億 | -7.01% |
| 12/15 | 5,383 | 5,385 | 5,217 | 5,230 | -3.51% | 1,997,200 | 2兆9174億 | -6.36% |
| 12/14 | 5,540 | 5,571 | 5,396 | 5,420 | -2.54% | 1,290,600 | 3兆234億 | -3.08% |
| 12/13 | 5,652 | 5,660 | 5,560 | 5,561 | -2.46% | 942,300 | 3兆1021億 | -0.57% |
| 12/12 | 5,778 | 5,838 | 5,685 | 5,701 | +0.11% | 1,109,300 | 3兆1802億 | +2.11% |
| 12/11 | 5,653 | 5,707 | 5,617 | 5,695 | +2.01% | 907,600 | 3兆1768億 | +2.26% |
| 12/08 | 5,691 | 5,691 | 5,559 | 5,583 | -2.55% | 1,573,500 | 3兆1143億 | +0.45% |
| 12/07 | 5,760 | 5,779 | 5,711 | 5,729 | -0.49% | 877,100 | 3兆1958億 | +3.26% |
| 12/06 | 5,704 | 5,760 | 5,682 | 5,757 | +1.27% | 744,400 | 3兆2114億 | +4.29% |
| 12/05 | 5,704 | 5,732 | 5,676 | 5,685 | +0.12% | 886,200 | 3兆1712億 | +3.63% |
| 12/04 | 5,675 | 5,693 | 5,618 | 5,678 | -0.8% | 690,200 | 3兆1673億 | +4.01% |
| 12/01 | 5,733 | 5,745 | 5,692 | 5,724 | +0.62% | 928,000 | 3兆1930億 | +5.41% |
| 12/01 | （IR情報）8:00 米国子会社ファーマバイト社が女性の健康分野をサポートするボナファイドヘルス社を買収 |
| 11/30 | 5,624 | 5,735 | 5,606 | 5,689 | +1.21% | 4,310,300 | 3兆1735億 | +5.37% |
| 11/29 | 5,575 | 5,637 | 5,540 | 5,621 | -0.25% | 966,100 | 3兆1355億 | +4.67% |
| 11/28 | 5,605 | 5,638 | 5,573 | 5,635 | +0.05% | 801,300 | 3兆1434億 | +5.41% |
